Cyprumed

Cyprumed's oral delivery technology has advanced to the clinical stage, with MSD initiating a Phase I trial to test it. The development marks the first time the platform has moved from preclinical work into human testing, a key milestone for companies working on oral delivery of drugs that are otherwise given by injection. It highlights continued industry interest in alternatives to injectable biologics.